Patients with non-small cell lung cancer may now receive a PD-1 immunotherapy as second-line treatment after chemotherapy.
October 2, 2015
The approval of a combination of two immunotherapy drugs for melanoma represents a treatment milestone.
October 1, 2015
The vaccine could provide a new treatment option for patients with high-risk cervical pre-cancer.
September 25, 2015